$0.82 Earnings Per Share Expected for Xylem Inc (NYSE:XYL) This Quarter

Brokerages expect Xylem Inc (NYSE:XYL) to announce earnings per share (EPS) of $0.82 for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Xylem’s earnings, with estimates ranging from $0.80 to $0.84. Xylem posted earnings of $0.77 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 6.5%. The firm is expected to report its next quarterly earnings report before the market opens on Thursday, October 31st.

On average, analysts expect that Xylem will report full year earnings of $3.15 per share for the current financial year, with EPS estimates ranging from $3.12 to $3.20. For the next fiscal year, analysts anticipate that the company will report earnings of $3.61 per share, with EPS estimates ranging from $3.47 to $3.75. Zacks’ earnings per share averages are an average based on a survey of research firms that follow Xylem.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, August 1st. The industrial products company reported $0.79 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.79. Xylem had a return on equity of 19.23% and a net margin of 10.90%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the company earned $0.73 EPS. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year.

A number of research firms have recently issued reports on XYL. Credit Suisse Group downgraded shares of Xylem from an “outperform” rating to a “neutral” rating in a research report on Friday, August 2nd. Zacks Investment Research downgraded shares of Xylem from a “hold” rating to a “sell” rating and set a $82.00 price target for the company. in a research report on Monday. ValuEngine downgraded shares of Xylem from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Jefferies Financial Group began coverage on shares of Xylem in a research report on Friday, September 20th. They set a “buy” rating and a $90.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and eight have given a buy rating to the company’s stock. Xylem presently has a consensus rating of “Hold” and a consensus target price of $79.92.

In other Xylem news, insider Kenneth Napolitano sold 5,000 shares of Xylem stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $75.23, for a total value of $376,150.00. Following the completion of the sale, the insider now directly owns 46,228 shares of the company’s stock, valued at approximately $3,477,732.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Colin R. Sabol sold 4,099 shares of Xylem stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $78.37, for a total transaction of $321,238.63. Following the completion of the sale, the senior vice president now directly owns 33,518 shares of the company’s stock, valued at $2,626,805.66. The disclosure for this sale can be found here. Insiders have sold a total of 19,099 shares of company stock valued at $1,464,339 over the last 90 days. Insiders own 0.85% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the business. Meridian Wealth Management LLC purchased a new stake in shares of Xylem during the 1st quarter valued at $30,000. FinTrust Capital Advisors LLC grew its stake in shares of Xylem by 1,530.4% during the 2nd quarter. FinTrust Capital Advisors LLC now owns 375 shares of the industrial products company’s stock valued at $31,000 after buying an additional 352 shares during the period. Private Ocean LLC purchased a new stake in Xylem during the 2nd quarter worth $33,000. Valeo Financial Advisors LLC boosted its position in Xylem by 500.0% during the 3rd quarter. Valeo Financial Advisors LLC now owns 420 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 350 shares during the period. Finally, BSW Wealth Partners purchased a new stake in Xylem during the 1st quarter worth $45,000. 84.55% of the stock is owned by hedge funds and other institutional investors.

Shares of XYL stock traded up $1.36 during midday trading on Thursday, reaching $78.37. 25,235 shares of the company traded hands, compared to its average volume of 757,470. The firm’s 50 day simple moving average is $77.10 and its two-hundred day simple moving average is $78.95. Xylem has a 1-year low of $60.65 and a 1-year high of $85.39. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.47 and a quick ratio of 1.08. The firm has a market cap of $13.98 billion, a PE ratio of 27.23, a price-to-earnings-growth ratio of 1.49 and a beta of 1.19.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 26th. Investors of record on Thursday, August 29th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Wednesday, August 28th. This represents a $0.96 annualized dividend and a dividend yield of 1.22%. Xylem’s dividend payout ratio is currently 33.33%.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Recommended Story: Street Name

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.